Pouch Prevents HIV Transmission
In order to reduce mother-to-child transmission of HIV among resource-poor populations who have little to no access to healthcare services, a novel foil pouch for packaging infant antiretroviral medications such as nevirapine has been developed by The Pratt School of Engineering at Duke University. Due to the pouch’s long shelf life, mothers can receive prophylactic medications during their first or second trimester enabling mothers who deliver at home to administer NVP as recommended. Bench testing and field acceptability testing among nurses and pharmacists in Tanzania has been completed, and twelve months of stability testing is in process. The stability data to date shows less than a 2% change in concentration, as opposed to more than a 5% change for other available solutions. The acceptability data demonstrate that the pouch solution can successfully be administered by mothers in resource-constrained settings. In the future, clinical trials will document the pouch’s impact on HIV transmission reduction in such settings.
To read more about this project, download the full paper below. Or, there are newspaper and radio articles about the pouch in our news clippings archive.